Plain-English translation of NCT05662540 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a combined imaging scan called PET/MR that takes two types of pictures at the same time — one that shows how your cells are working and one that shows detailed anatomy. The study involves people newly diagnosed with NK/T-cell lymphoma, a rare and aggressive blood cancer. Researchers want to see if this combined scan is better than doing two separate scans, because it could give doctors a clearer picture of the cancer and how well treatment is working.
NK/T-cell lymphoma is aggressive and often spreads to multiple parts of the body, so doctors need very detailed pictures to find all the cancer and track how treatment is working. Currently, patients have to get two different scans that can't be combined, which is inconvenient and less precise. This trial exists to see if one combined scan could do a better job while being easier on patients.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have a combined PET/MR scan before you start cancer treatment. Depending on whether your cancer is early-stage or advanced, you'll return for additional scans after a few rounds of treatment to see how well it's working. After that, you'll have follow-up appointments every 3 months for the first year, then every 6 months, where your doctors will check your symptoms, do physical exams, and sometimes order follow-up scans to make sure the cancer stays under control.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China
Sponsor
Ruijin Hospital
Enrollment target
~40 participants
Started
May 2023
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
14 Years – 70 Years
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Weili Zhao
Ruijin Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.